| This week's sponsor is RAPS. | | | |
Today's Rundown Decibel signs unique partnership deal with Regeneron for hearing programs Codiak raises $77M to trial exosome-enabled therapies Biotech veterans, chasing Merck and Novartis, tap Frazier, Alpine for cash to move STING modulators into the clinic [Sponsored] What makes a modern-day biotech? Duke engineers create fully functional beating heart patch Biocartis raises €80M to help drive liquid biopsy push Charles River’s capture compound mass spectrometry enables Enyo Pharma’s target identification The Medicines Co., in pivot to pipeline PCSK9 med, secures $270M asset sale Featured Story | | | Wednesday, November 29, 2017 Decibel Therapeutics has forged an unusual alliance with Regeneron that gives it access to the big biotech’s scientific expertise—without giving away rights to its drug candidates for hearing loss and tinnitus. |
|
|
| This week's sponsor is Charles River. | | | |
Top Stories Wednesday, November 29, 2017 Codiak BioSciences has raised $76.5 million. The series C, which moves Codiak’s total haul up toward $170 million, tees the exosome-focused biotech up to move its lead candidate into clinical trials. Wednesday, November 29, 2017 A team of biotech veterans has pulled in $20 million to advance modulators of the STING pathway into human testing. The series A positions the startup, Mavupharma, to further its preclinical work on the use of oral STING modulators to treat cancer and infectious diseases. Monday, November 27, 2017 Blue Latitude Health interviews 6 biotech leaders to reveal the commercial challenges and opportunities in 2018 and beyond, including big data, FDA approvals, combination therapies, empowered patients and the skills crisis. Wednesday, November 29, 2017 After a heart attack, scar tissue that can’t contract typically replaces dead cardiac muscle, resulting in chronic heart failure—a scourge affecting 12 million people around the world. Engineers at Duke University say they’ve created an artificial heart muscle that can be used to patch up the damage in patients who have suffered heart attacks. Wednesday, November 29, 2017 Belgian molecular diagnostics outfit Biocartis says an €80 million private placement will allow it to expand its product range and sales and manufacturing capacity. Wednesday, November 29, 2017 Using Charles River Laboratories’ recently acquired capture compound mass spectrometry technology, Enyo Pharma has successfully identified potential targets of its preclinical molecule series EYP002. Wednesday, November 29, 2017 The Medicines Company is going all-in on pipeline cholesterol drug inclisiran. On Wednesday, the company inked a deal to sell several marketed infectious disease meds to Melinta Therapeutics to gin up cash to support development for the blockbuster hopeful. Resources Sponsored by: Veeva Systems Read Deloitte Consulting's whitepaper on the value of a holistic RIM capability, covering the potential cost savings and revenue gains from doing RIM right. Presented By: Covance Global clinical trials are the trend and gaining in popularity, but running a global trial is not a straightforward process. This white paper explores some of the challenges associated with global clinical trials and considerations for ensuring that the collected data comply with the trial's overall objectives. Sponsored by: Veeva Systems See the results from one of the largest, most in-depth surveys of clinical data management professionals on data management practices, performance, and challenges. Sponsored by: Veeva Systems Gain a complete, real-time view of quality and streamline operations. Incorporate partners into processes for critical oversight and 30% greater efficiency, and transform cross-functional processes like change control. Presented by: DSM Biomedical Discover DSM's Dyneema Purity® membrane, an effective and efficient material to construct stent grafts used in minimally invasive surgeries to treat both cardiovascular and peripheral arterial diseases. Sponsored by: ePharmaSolutions As clinical trials become more complex, safety document distribution to investigative sites has reached the point that demands a solution. Sponsored by: Ashfield Healthcare December 5, 2017 | 2pm EST / 11am PST Join this webinar to learn methods that maintain and build sales momentum despite turnover. Sponsored by: Veeva CROs are leading an industry wide shift to modernize clinical systems and clinical trial processes. Presented By: Charles River Join us as we discuss how Charles River Celsis® helped Labor L+S AG validate a 7-day membrane filtration sterility test using existing protocols. Presented By: Catalent Learn how Catalent Biologics is paving the way for flexible biologics development and manufacturing through advanced technologies and fully integrated multi-product facility. Presented By: Catalent Download the eBook to get articles from various Elsevier journals highlighting developments in ADC technology. Presented By: Catalent Learn how cell development and process scale-up can be optimized for antibodies requiring additional processing. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. BioBasics: Biotech for the Non-Scientist November 30-December 1, 2017 | Boston, MA FierceBiotech Executive Breakfast: Get Good Science and the Money will Follow January 9, 2018 | San Francisco, CA BIO Asia International Conference March 19-20, 2018 | Tokyo, Japan Molecular Med Tri-Conference February 11-16, 2018 | San Francisco, CA | 